CAPO Health review

CAPO Health’s terms identify C.A.P.O Health Corp as the platform operator. Its provider page names Arora Health & Aesthetics, LLC, and its pharmacy page identifies The Pharmacy Hub in Miami. CAPO says it does not practice medicine, compound or dispense prescriptions itself.

Publishing these names is more useful than a generic licensed-pharmacy claim: patients have specific organizations to ask about prescriptions, dispensing and problems with an order. Use our compounding-pharmacy verification guide to check the dispensing details. It is still not an independent verification of a particular clinician’s license, a pharmacy inspection history or the safety of an individual preparation.

The semaglutide page lists $175 billed monthly and a separate $175 one-time purchase for a one-month supply. Tirzepatide has the same choice at $235. The one-time option says there are no automatic renewals and that another order can be requested from the patient portal. That distinction matters for someone who wants to avoid a continuing subscription.

The product pages say the price is the same at every prescribed dose and includes medication, supplies, provider access and shipping, without a separate enrollment, consultation or membership fee. They also say the final price is confirmed after provider review; the legal terms call website prices illustrative until the plan is confirmed.

Semaglutide is listed at $435 every three months, $720 every six months or $1,188 every twelve months. Those charges correspond to $145, $120 and $99 a month. Tirzepatide is $597 every three months, $1,050 every six months or $1,620 every twelve months, equivalent to $199, $175 and $135 a month.

The $99 and $135 figures are not month-to-month payment options. Before prepaying, confirm how many shipments the plan provides, how the prescription changes with dose, and what happens to unused prepaid treatment if the clinician stops or changes therapy. The public refund policy does not clearly promise a prorated refund of an unused long-term balance.

CAPO’s treatment pages say payment is collected before a licensed clinician reviews the file. If treatment is not appropriate, the site promises that nothing will be dispensed and the order will be refunded in full. A completed payment is therefore not approval for treatment.

The refund policy allows cancellation through the account or support without a cancellation fee, stopping future billing and shipments. It generally excludes already dispensed medication from refunds, with exceptions for pharmacy-confirmed errors, transit damage or a missing shipment. For a prepaid plan, ask exactly which portion remains refundable before paying rather than relying on cancel-anytime language; our cancellation and refund guide explains the distinction.

CAPO’s state page advertises nationwide service but qualifies it by provider licensure, pharmacy authority, medication and formulation. The clinical review must establish eligibility where the patient is located; a general 50-state claim does not promise every treatment in every state.

The shipping policy names The Pharmacy Hub as the shipper and says tracking is provided after dispatch, with timing varying by destination and carrier. It describes protective and temperature-controlled packaging when required. Report delays or damage promptly and confirm the address before dispensing, because the policy says dispensed orders cannot be rerouted.

CAPO offers a comparatively detailed public price menu and a genuine distinction between one-time and renewing orders. The one-month options are easier to evaluate than a full-year purchase for someone who has not yet established how treatment fits their needs.

All reviewed injection offers are compounded, not FDA-approved generic equivalents. Naming a clinical group and pharmacy does not remove that limitation. The most important unresolved financial question is the treatment of unused prepaid medication, while the clinical decision remains with the prescriber.